首页 | 本学科首页   官方微博 | 高级检索  
检索        

肝动脉及门静脉双插管化疗治疗不能切除原发性肝癌22例分析
引用本文:袁永胜,马福顺.肝动脉及门静脉双插管化疗治疗不能切除原发性肝癌22例分析[J].中国肿瘤临床,1995,22(9):624-626.
作者姓名:袁永胜  马福顺
作者单位:山东省寿光市人民医院外一科,解放军二六二医院外三科
摘    要:报道22例不能切除的原发性肝癌,经肝动脉及门静脉双插管灌注化疗后,肿瘤缩小率为85.8%~13.3%,平均缩小率为39.5%。生存率6月95.5%,1年81.8%,2年36.4%。

关 键 词:肝肿瘤,肝动脉,门静脉,插管化疗

Treatment of Nonresectable Primary Liver Cancer with Chemotherapy by Double Infusion via Hepatic Artery and Portal Vein. A Report of 22 Cases
Yuan Yong-Sheng,Xi Wen-Qing,Zhang Xian-Zhong, et al.Treatment of Nonresectable Primary Liver Cancer with Chemotherapy by Double Infusion via Hepatic Artery and Portal Vein. A Report of 22 Cases[J].Chinese Journal of Clinical Oncology,1995,22(9):624-626.
Authors:Yuan Yong-Sheng  Xi Wen-Qing  Zhang Xian-Zhong  
Abstract:Twenty-two cases with nonresectable primary liver cancer were treated by chemotherpay through double intubation by the way of hepatic artery and Portal vein. The rate of tumor shinkage was seen in 85.8%-13.3% (average 39.5% of cases). The survival rate at 6 months,1 and 2 years after treatment were 95.5%, 81.8% and 36.4% respectively.
Keywords:Liver cancer  Hepatic artery  Portal vein  Infusion chemotherapy  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号